West Virginia

West Virginia

State Facts

619

Deaths, or 76.1% of total overdose deaths involved opioids in 2024.¹

412,072

Claims, or 3.55% of all Medicare Part D claims were for opioids in 2022 – an average of 50 per prescriber.²

46.4

Opioid Prescriptions were written for every 100 persons in West Virginia in 2023.³

7,871

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$980,944,656.58
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Rep. Carol Miller (R-WV-1)

Rep. Carol Miller (R-WV-1)

Sen. Shelley Moore Capito (R-WV)

Sen. Shelley Moore Capito (R-WV)

Sen. James

Sen. James "Jim" Justice (R-WV)

2025 Introduced Relevant Legislation

HB 3070/SB 628

These bills ensure that FDA-approved non-opioid pain treatments are not disadvantaged or discouraged in coverage compared to opioids in state medicaid and state regulated health plans.

Introduced
03/03/2025
Plan Impact
Commercial & Medicaid
Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf